A recent study by Koornstra et al. examined FasL expression and apoptosis in colorectal tumors from Lynch Syndrome patients to assess whether Fas counterattack had a role in Lynch Syndrome pathology or clinical manifestations, in particular, the accelerated transformation from adenoma to tumor [148]. This evidence concerns the gene FASLG and Lynch syndrome.